Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$70,524,421
-$5,840,834 QoQ
Shares Held
277,688
-11.1% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#372
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Sep 30, 2023CallValue
$34,109
CallShares
21,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $233,466,304 across 14 Drug Manufacturers - General names. JNJ ranks #1 (30.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
277,688 | $70,524,421 | |
| 2 | ABBV |
AbbVie Inc.
|
233,214 | $58,685,970 | |
| 3 | MRK |
Merck & Co., Inc.
|
266,566 | $34,253,731 | |
| 4 | AMGN |
Amgen Inc
|
55,311 | $20,029,219 | |
| 5 | PFE |
Pfizer Inc
|
744,034 | $17,916,338 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
194,227 | $11,191,359 | |
| 7 | AZN |
Astrazeneca PLC
|
30,398 | $5,764,068 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
43,759 | $5,528,512 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,524,421 | 277,688 | Shares | Other | 2026-07-27 | |
| 2026-03-31 | $76,365,255 | 312,409 | Shares | Other | 2026-04-27 | |
| 2025-12-31 | $63,730,045 | 307,949 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $53,395,026 | 287,968 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $39,646,568 | 259,552 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $42,183,062 | 254,360 | Shares | Other | 2025-05-05 | |
| 2024-12-31 | $62,974,633 | 435,449 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $41,741,794 | 257,570 | Shares | Other | 2024-10-22 | |
| 2024-06-30 | $37,738,512 | 258,200 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $40,710,671 | 257,353 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $41,080,927 | 262,096 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $40,645,921 | 260,969 | Shares | Other | 2023-11-03 | |
| 2023-09-30 | $34,109 | 21,900 | Call | Sole | 2023-11-03 | |
| 2023-06-30 | $45,507,572 | 274,937 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $43,358,305 | 279,731 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $48,809,808 | 276,308 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $45,004,209 | 275,491 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $71,528,364 | 402,954 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $71,676,242 | 404,425 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $64,914,906 | 379,464 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $97,891,771 | 606,141 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $64,086,001 | 389,013 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $59,250,640 | 360,515 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $49,237,749 | 312,859 | Shares | Sole | 2021-04-01 | |
| 2020-09-30 | $45,167,809 | 303,384 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $42,493,182 | 302,163 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $37,326,679 | 284,654 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||